Rational vaccinology with spherical nucleic acids

In the case of cancer immunotherapy, nanostructures are attractive because they can carry all of the necessary components of a vaccine, including both antigen and adjuvant. Herein, we explore how spherical nucleic acids (SNAs), an emerging class of nanotherapeutic materials, can be used to deliver p...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 116; no. 21; pp. 10473 - 10481
Main Authors Wang, Shuya, Qin, Lei, Yamankurt, Gokay, Skakuj, Kacper, Huang, Ziyin, Chen, Peng-Cheng, Dominguez, Donye, Lee, Andrew, Zhang, Bin, Mirkin, Chad A.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 21.05.2019
SeriesPNAS Plus
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In the case of cancer immunotherapy, nanostructures are attractive because they can carry all of the necessary components of a vaccine, including both antigen and adjuvant. Herein, we explore how spherical nucleic acids (SNAs), an emerging class of nanotherapeutic materials, can be used to deliver peptide antigens and nucleic acid adjuvants to raise immune responses that kill cancer cells, reduce (or eliminate) tumor growth, and extend life in three established mouse tumor models. Three SNA structures that are compositionally nearly identical but structurally different markedly vary in their abilities to cross-prime antigen-specific CD8⁺ T cells and raise subsequent antitumor immune responses. Importantly, the most effective structure is the one that exhibits synchronization of maximum antigen presentation and costimulatory marker expression. In the human papillomavirus-associated TC-1 model, vaccination with this structure improved overall survival, induced the complete elimination of tumors from 30% of the mice, and conferred curative protection from tumor rechallenges, consistent with immunological memory not otherwise achievable. The antitumor effect of SNA vaccination is dependent on the method of antigen incorporation within the SNA structure, underscoring the modularity of this class of nanostructures and the potential for the deliberate design of new vaccines, thereby defining a type of rational cancer vaccinology.
Bibliography:1S.W. and L.Q. contributed equally to this work.
Contributed by Chad A. Mirkin, March 28, 2019 (sent for review February 19, 2019; reviewed by Omid Farokhzad and David J. Mooney)
Author contributions: S.W., L.Q., G.Y., A.L., B.Z., and C.A.M. designed research; S.W., L.Q., and K.S. performed research; Z.H. contributed new reagents/analytic tools; S.W., L.Q., G.Y., K.S., Z.H., P.-C.C., D.D., A.L., B.Z., and C.A.M. analyzed data; and S.W., L.Q., A.L., B.Z., and C.A.M. wrote the paper.
Reviewers: O.F., Harvard Medical School–Brigham and Women’s Hospital; and D.J.M., Harvard University.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1902805116